Asia-Pacific Flow Cytometry Market - Industry Trends and Forecast to 2029
- Published Date: 2022-11-22
- Report ID: 144162
- Pages: 200
-
Format:
Short Description
Asia-Pacific Flow Cytometry Market, By Product (Flow Cytometry Instruments, Reagents and Consumables, Software, Accessories, and Services), Technology (Cell-Based Flow Cytometry, and Bead-Based Flow Cytometry), Application (Research Applications, Clinical Applications, and Industrial Applications), End User (Academic & Research Institutes, Hospitals, Pharmaceutical & Biotechnology Companies, Clinical Testing Laboratories, Blood Bank, and Others), Distribution Channel (Direct Tenders, and Retail Sales), Country (Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines and Rest of Asia-Pacific) - Industry Trends and Forecast to 2029
Market Definition:
Flow cytometry is a key process for screening cells from a heterologous cell mixture used in cell sorting, counting, protein regeneration, and engineering. Flow cytometry has many applications for research and clinical purposes, including cancer diagnosis, chromosome identification, and protein expression. Flow cytometry can identify the physiochemical properties of the cells and parameters related to the single-based cells. They use fluorescent probes to identify and characterize each cell. The common type of flow cytometry instruments available is cells analyzers and cell sorters, in which cell analyzers are used for the analysis of cells from a heterologous cell population, whereas cell sorters are used as cell sorting.
Flow cytometry is a technology that provides rapid multi-parametric analysis of single cells in solution. They utilize lasers as a light source and produce scattered and fluorescent light signals that get detected by detectors such as photodiodes or photomultiplier tubes attached to the cytometer. These analyses are widely used to evaluate bone marrow, peripheral blood, and other fluids in the body.
Market Segmentation:
The Asia-Pacific flow cytometry market is categorized into five notable segments based on product, technology, application, end user, and distribution channel.
On the basis of product, the Asia-Pacific flow cytometry market is segmented into reagents and consumables, flow cytometry instruments, software, accessories, and services
On the basis of technology, the Asia-Pacific flow cytometry market is segmented into cell-based flow cytometry and bead-based flow cytometry
On the basis of application, the Asia-Pacific flow cytometry market is segmented into research applications, clinical applications, and industrial applications
On the basis of end user, the Asia-Pacific flow cytometry market is segmented into academic & research institutes, hospitals, pharmaceutical & biotechnology companies, clinical testing laboratories, blood bank, and others
On the basis of distribution channel, the Asia-Pacific flow cytometry market is segmented into direct tenders and retail sales
Market Players
Some of the key market players in the Asia-Pacific flow cytometry market are listed below:
Sysmex Asia Pacific Pte Ltd
Agilent Technologies, Inc.
BD
Bio-Rad Laboratories, Inc.
Beckman Coulter, Inc. (A subsidiary of Danaher Corporation)
Luminex Corporation
Sony Biotechnology Inc.
Apogee Flow Asia Ltd.
Cytek Biosciences
bioMrieux SA
Merck KGaA
Elabscience Biotechnology Inc.
Miltenyi Biotec
Takara Bio Inc.
Thermo Fisher Scientific Inc.
Q2 Solutions
CellKraft Biotech Pvt. Ltd.
Sartorius AG
NeoGenomics Laboratories
Bay bioscience Co., Ltd.
Cell Signaling Technology, Inc.
CytoBuoy b.v.
ORFLO Technologies
IKEDA SCIENTIFIC Co., Ltd.
BioLegend, Inc.
II-VI Incorporated
TABLE OF CONTENTS
1 INTRODUCTION 20
1.1 OBJECTIVES OF THE STUDY 20
1.2 MARKET DEFINITION 20
1.3 OVERVIEW OF ASIA-PACIFIC FLOW CYTOMETRY MARKET 20
1.4 LIMITATIONS 22
1.5 MARKETS COVERED 22
2 MARKET SEGMENTATION 25
2.1 MARKETS COVERED 25
2.2 GEOGRAPHICAL SCOPE 26
2.3 YEARS CONSIDERED FOR THE STUDY 26
2.4 CURRENCY AND PRICING 26
2.5 DBMR TRIPOD DATA VALIDATION MODEL 27
2.6 MULTIVARIATE MODELLING 30
2.7 PRODUCT LIFELINE CURVE 30
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 31
2.9 DBMR MARKET POSITION GRID 32
2.10 MARKET APPLICATION COVERAGE GRID 33
2.11 VENDOR SHARE ANALYSIS 34
2.12 SECONDARY SOURCES 35
2.13 ASSUMPTIONS 35
3 EXECUTIVE SUMMARY 36
4 PREMIUM INSIGHTS 39
5 REGULATIONS 40
5.1 REGULATIONS IN ASIA-PACIFIC FLOW CYTOMETRY MARKET 40
5.1.1 REGULATIONS IN INDIA 40
5.1.2 REGULATIONS IN CHINA 41
5.1.3 REGULATIONS IN JAPAN 41
5.1.4 REGULATIONS IN AUSTRALIA 41
6 MARKET OVERVIEW 43
6.1 DRIVERS 45
6.1.1 RISING PREVALENCE OF CHRONIC DISEASES 45
6.1.2 INCREASING APPLICATION OF CYTOMETRY INSTRUMENTS 45
6.1.3 INCREASE IN USE OF FLOW CYTOMETRY IN DRUG DISCOVERY 46
6.1.4 GROWTH IN STEM CELL RESEARCH AND ACQUISITION OF RECOMBINATION OF DNA TECHNOLOGIES 47
6.2 RESTRAINTS 47
6.2.1 HIGH COST OF FLOW CYTOMETRY INSTRUMENTS 47
6.2.2 LIMITATIONS OF FLOW CYTOMETRY 48
6.3 OPPORTUNITIES 48
6.3.1 INCREASE IN ADOPTION OF FLOW CYTOMETRY TECHNIQUES IN RESEARCH AND ACADEMIA 48
6.3.2 WIDE DEVELOPMENT IN PHARMACEUTICAL AND BIOTECHNOLOGY INDUSTRIES 49
6.3.3 STRATEGIC INITIATIVES BY MARKET PLAYERS 49
6.3.4 DEVELOPING PIPELINE OF STEM CELL RESEARCH 50
6.4 CHALLENGES 50
6.4.1 DIFFICULTY IN DEVELOPMENT AND VALIDATION OF FLOW CYTOMETRY ASSAYS 50
6.4.2 COMPLEXITIES RELATED TO REAGENT DEVELOPMENT 51
7 IMPACT OF COVID-19 ON ASIA-PACIFIC FLOW CYTOMETRY MARKET 52
7.1 PRICE IMPACT 52
7.2 IMPACT ON DEMAND 52
7.3 IMPACT ON SUPPLY CHAIN 53
7.4 STRATEGIC DECISIONS FOR MANUFACTURERS 54
7.5 CONCLUSION 54
8 ASIA-PACIFIC FLOW CYTOMETRY MARKET, BY PRODUCT 55
8.1 OVERVIEW 56
8.2 REAGENTS AND CONSUMABLES 59
8.2.1 ANTIBODIES 60
8.2.2 DYES 60
8.2.3 BEADS 60
8.2.4 OTHERS 60
8.3 FLOW CYTOMETRY INSTRUMENTS 60
8.3.1 CELL ANALYZERS 61
8.3.1.1 IMAGING FLOW CYTOMETERS 61
8.3.1.2 NON-IMAGING FLOW CYTOMETERS 61
8.3.1.3 BENCHTOP 62
8.3.1.4 STANDALONE 62
8.3.2 CELL SORTERS 62
8.3.2.1 BENCHTOP 62
8.3.2.2 STANDALONE 62
8.4 ACCESSORIES 62
8.4.1 FILTERS 63
8.4.2 DETECTORS 63
8.4.3 OTHERS 63
8.5 SERVICES 63
8.6 SOFTWARE 64
9 ASIA-PACIFIC FLOW CYTOMETRY MARKET, BY TECHNOLOGY 65
9.1 OVERVIEW 66
9.2 CELL-BASED FLOW CYTOMETRY 69
9.3 BEAD-BASED FLOW CYTOMETRY 69
10 ASIA-PACIFIC FLOW CYTOMETRY MARKET, BY APPLICATION 71
10.1 OVERVIEW 72
10.2 RESEARCH APPLICATIONS 75
10.2.1 CELL CYCLE ANALYSIS 76
10.2.2 CELL SORTING/SCREENING 76
10.2.3 CELL TRANSFECTION/VIABILITY 76
10.2.4 PHARMACEUTICAL AND BIOTECHNOLOGY 76
10.2.4.1 DRUG DISCOVERY 77
10.2.4.2 STEM CELL RESEARCH 77
10.2.4.3 IN VITRO TOXICITY TESTING 77
10.2.5 IMMUNOLOGY 77
10.2.6 APOPTOSIS 77
10.2.7 CELL COUNTING 77
10.2.8 OTHERS 77
10.3 CLINICAL APPLICATIONS 77
10.3.1 HAEMATOLOGY 78
10.3.2 CANCER 78
10.3.3 IMMUNODEFICIENCY DISEASES 78
10.3.4 ORGAN TRANSPLANTATION 79
10.3.5 OTHER CLINICAL APPLICATION 79
10.4 INDUSTRIAL APPLICATIONS 79
11 ASIA-PACIFIC FLOW CYTOMETRY MARKET, BY END USER 80
11.1 OVERVIEW 81
11.2 ACADEMIC & RESEARCH INSTITUTES 84
11.3 PHARMACEUTICALS & BIOTECHNOLOGY COMPANIES 84
11.4 HOSPITALS 85
11.5 CLINICAL TESTING LABORATORIES 85
11.6 BLOOD BANK 85
11.7 OTHERS 86
12 ASIA-PACIFIC FLOW CYTOMETRY MARKET, BY DISTRIBUTION CHANNEL 87
12.1 OVERVIEW 88
12.2 RETAIL SALES 91
12.3 DIRECT TENDERS 91
13 ASIA-PACIFIC FLOW CYTOMETRY MARKET, BY COUNTRY 92
13.1 JAPAN 98
13.2 CHINA 102
13.3 INDIA 106
13.4 SOUTH KOREA 110
13.5 AUSTRALIA 114
13.6 SINGAPORE 118
13.7 THAILAND 122
13.8 MALAYSIA 126
13.9 INDONESIA 130
13.10 PHILIPPINES 134
13.11 REST OS ASIA-PACIFIC 138
14 ASIA-PACIFIC FLOW CYTOMETRY MARKET: COMPANY LANDSCAPE 139
14.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 139
15 SWOT ANALYSIS 140
16 COMPANY PROFILE 141
16.1 THERMO FISHER SCIENTIFIC INC. 141
16.1.1 COMPANY SNAPSHOT 141
16.1.2 REVENUE ANALYSIS 141
16.1.3 PRODUCT PORTFOLIO 142
16.1.4 RECENT DEVELOPMENTS 143
16.1.5 ACQUISITION 143
16.2 BD 144
16.2.1 COMPANY SNAPSHOT 144
16.2.2 REVENUE ANALYSIS 144
16.2.3 PRODUCT PORTFOLIO 145
16.2.4 RECENT DEVELOPMENT 145
16.2.5 COLLABORATION 145
16.3 AGILENT TECHNOLOGIES, INC. 146
16.3.1 COMPANY SNAPSHOT 146
16.3.2 REVENUE ANALYSIS 146
16.3.3 PRODUCT PORTFOLIO 147
16.3.4 RECENT DEVELOPMENT 148
16.3.5 ACQUISITION 148
16.4 SARTORIUS AG 149
16.4.1 COMPANY SNAPSHOT 149
16.4.2 REVENUE ANALYSIS 149
16.4.3 PRODUCT PORTFOLIO 150
16.4.4 RECENT DEVELOPMENTS 150
16.5 II-VI INCORPORATED 151
16.5.1 COMPANY SNAPSHOT 151
16.5.2 REVENUE ANALYSIS 151
16.5.3 PRODUCT PORTFOLIO 152
16.5.4 RECENT DEVELOPMENTS 152
16.5.5 PRODUCT LAUNCH 152
16.5.6 AWARDS 152
16.6 APOGEE FLOW ASIA LTD. 153
16.6.1 COMPANY SNAPSHOT 153
16.6.2 PRODUCT PORTFOLIO 153
16.6.3 RECENT DEVELOPMENT 153
16.6.4 PRODUCT LAUNCH 153
16.7 BAY BIOSCIENCE CO., LTD. 154
16.7.1 COMPANY SNAPSHOT 154
16.7.2 PRODUCT PORTFOLIO 154
16.7.3 RECENT DEVELOPMENT 154
16.8 BECKMAN COULTER, INC. (A SUBSIDIARY OF DANAHER CORPORATION) 155
16.8.1 COMPANY SNAPSHOT 155
16.8.2 REVENUE ANALYSIS 155
16.8.3 PRODUCT PORTFOLIO 156
16.8.4 RECENT DEVELOPMENTS 157
16.8.5 ACQUISITION 157
16.8.6 PRODUCT LAUNCH 157
16.9 BIOLEGEND, INC. 158
16.9.1 COMPANY SNAPSHOT 158
16.9.2 PRODUCT PORTFOLIO 158
16.9.3 RECENT DEVELOPMENT 160
16.9.4 ACQUISITION 160
16.10 BIOMRIEUX SA. 161
16.10.1 COMPANY SNAPSHOT 161
16.10.2 REVENUE ANALYSIS 161
16.10.3 PRODUCT PORTFOLIO 162
16.10.4 RECENT DEVELOPMENT 162
16.11 BIO-RAD LABORATORIES, INC. 163
16.11.1 COMPANY SNAPSHOT 163
16.11.2 REVENUE ANALYSIS 163
16.11.3 PRODUCT PORTFOLIO 164
16.11.4 RECENT DEVELOPMENT 164
16.12 CELLKRAFT BIOTECH PVT. LTD 165
16.12.1 COMPANY SNAPSHOT 165
16.12.2 PRODUCT PORTFOLIO 165
16.12.3 RECENT DEVELOPMENT 166
16.13 CELL SIGNALING TECHNOLOGY, INC. 167
16.13.1 COMPANY SNAPSHOT 167
16.13.2 PRODUCT PORTFOLIO 167
16.13.3 RECENT DEVELOPMENT 168
16.14 CYTEK BIOSCIENCES. 169
16.14.1 COMPANY SNAPSHOT 169
16.14.2 PRODUCT PORTFOLIO 169
16.14.3 RECENT DEVELOPMENTS 170
16.14.4 PRODUCT LAUNCH 170
16.14.5 ACQUISITION 170
16.15 CYTOBUOY B.V. 171
16.15.1 COMPANY SNAPSHOT 171
16.15.2 PRODUCT PORTFOLIO 171
16.15.3 RECENT DEVELOPMENT 171
16.16 ELABSCIENCE BIOTECHNOLOGY INC. 172
16.16.1 COMPANY SNAPSHOT 172
16.16.2 PRODUCT PORTFOLIO 172
16.16.3 RECENT DEVELOPMENT 173
16.17 IKEDA SCIENTIFIC CO., LTD. 174
16.17.1 COMPANY SNAPSHOT 174
16.17.2 PRODUCT PORTFOLIO 174
16.17.3 RECENT DEVELOPMENT 174
16.18 LUMINEX CORPORATION 175
16.18.1 COMPANY SNAPSHOT 175
16.18.2 REVENUE ANALYSIS 175
16.18.3 PRODUCT PORTFOLIO 176
16.18.4 RECENT DEVELOPMENTS 177
16.18.5 PRODUCT LAUNCH 177
16.19 MERCK KGAA 178
16.19.1 COMPANY SNAPSHOT 178
16.19.2 REVENUE ANALYSIS 178
16.19.3 PRODUCT PORTFOLIO 179
16.19.4 RECENT DEVELOPMENTS 179
16.19.5 COLLABORATION/ AGREEMENT 179
16.20 MILTENYI BIOTEC 181
16.20.1 COMPANY SNAPSHOT 181
16.20.2 PRODUCT PORTFOLIO 181
16.20.3 RECENT DEVELOPMENTS 183
16.20.4 PRODUCT LAUNCH 183
16.21 NEOGENOMICS LABORATORIES 184
16.21.1 COMPANY SNAPSHOT 184
16.21.2 REVENUE ANALYSIS 184
16.21.3 PRODUCT PORTFOLIO 185
16.21.4 RECENT DEVELOPMENT 185
16.22 ORFLO TECHNOLOGIES 186
16.22.1 COMPANY SNAPSHOT 186
16.22.2 PRODUCT PORTFOLIO 186
16.22.3 RECENT DEVELOPMENT 187
16.22.4 COLLABORATION 187
16.23 Q2 SOLUTION 188
16.23.1 COMPANY SNAPSHOT 188
16.23.2 REVENUE ANALYSIS 188
16.23.3 SERVICE PORTFOLIO 189
16.23.4 RECENT DEVELOPMENT 189
16.24 SONY BIOTECHNOLOGY INC. 190
16.24.1 COMPANY SNAPSHOT 190
16.24.2 PRODUCT PORTFOLIO 190
16.24.3 RECENT DEVELOPMENT 192
16.25.4 RECENT DEVELOPMENT 194
16.25.5 ACQUISITION 194
16.26 TAKARA BIO INC. 195
16.26.1 COMPANY SNAPSHOT 195
16.26.2 REVENUE ANALYSIS 195
16.26.3 PRODUCT PORTFOLIO 196
16.26.4 RECENT DEVELOPMENTS 196
17 QUESTIONNAIRE 197
18 RELATED REPORTS 200
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
